Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Frank Buck who wrote (1394)	2/5/1998 1:03:00 PM
From: Sigmund	Respond to of 1894

No and I am so hurt. This latest piece of information seems to have put the two of you in a very good mood. Remember, information spelled backwards is noitamrofni. Perhaps the Noitamrofni Group will make a run on our company. Apparently they are very interested in companies which are going backwards. To them, ACMI is about to hit a new high. I can't wait. I understand that Dana is also getting into the swing of things. Instead of the company issuing press releases in the future telling us what is happening, the new procedure is that we as investors, potential investors, or existing and potential short sellers are to send to her what we think is happening. Hopefully you have provided any juicy pieces of information to Dana. She will then package this information appropriately with the usual warning about backward looking statements as called for under the Unsafe Harbor Act. Remember in the world of noitamrofni, good news is bad news and bad news is good news. On a serious note, it is clear to me that the market is making some preliminary decisions as to who the players are in this sector. Cytec is clearly in, NSIX is out, NeoPath is out, ACYT is out. Is ACMI in or out? I think it would have been in sans the latest screw up. It is still possible for ACMI to be in but not very likely. I think the company is now negotiating the exit strategy. If so, I think they are doing the right thing. It would provide existing shareholders with some improvement in their investing experience with this company. The company has a lot of valuable technology and finding a good home for this technology makes sense. The other alternative is to obtain the financing that would allow this technology to be brought to market. This is far riskier but of course has a potentially greater reward. Hopefully the company will make a wise choice and get on with enhancing shareholder value rather than courting the Noitamrofni's of this world.